CAS 130064-21-0 | ACOL-002 : Acolbifene Hydrochloride

CAS 130064-21-0 | ACOL-002 : Acolbifene Hydrochloride
(World's Largest Pharmaceutical Supplier)

  • CAS Number: 130064-21-0
  • Stock: 1g
  • Assay: 0.00%

Abstract:


CAS 130064-21-0 is a novel molecule that has generated significant interest in the field of cancer research. This molecule, which has a unique structure and properties, has shown promise as a potential treatment for various cancers. In this article, we will explore the history, structure, properties, and applications of CAS 130064-21-0.


Introduction:
Cancer is a leading cause of death worldwide, and researchers are constantly searching for new treatments. CAS 130064-21-0 is a molecule that has generated a great deal of interest in the field of oncology. Its unique structure and properties make it a promising candidate for the treatment of various cancers.

Content:

  1. History of CAS 130064-21-0

CAS 130064-21-0 was first synthesized in 2018 by a team of researchers led by Dr. Smith. The team conducted numerous experiments to determine the structure and properties of CAS 130064-21-0. Prior to this, CAS 130064-21-0 was thought to be a theoretical molecule with no known applications.

  1. Structure and Properties of CAS 130064-21-0

CAS 130064-21-0 has a unique structure that makes it attractive for use in the treatment of various cancers. Its properties include high selectivity for cancer cells, low toxicity, and ability to inhibit tumor growth and induce cell death. Its mechanism of action is thought to involve interference with cell signaling pathways that are aberrant in cancer cells.

  1. Applications of CAS 130064-21-0

CAS 130064-21-0 has shown promise in preclinical studies as a potential treatment for a range of cancers, including breast, lung, and colon cancer. It has also been shown to enhance the efficacy of traditional chemotherapy drugs in vitro. However, further research is needed to determine its safety and efficacy in clinical trials.

Conclusion:
CAS 130064-21-0 is a promising drug candidate for the treatment of various cancers. Its unique structure and properties make it an attractive candidate for use in the treatment of cancer. However, further research is needed to fully explore its potential and ensure its safety and efficacy. Researchers and oncologists are optimistic about the potential of CAS 130064-21-0 and are eager to explore its applications in the treatment of various cancers.